References
- Abdullaev FI. (1993). Biological effects of saffron. Biofactors, 4, 83–86.
- Abdullaev FI, Espinosa-Aguirre JJ. (2004). Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev, 28, 426–432.
- Abe K, Saito H. (2000). Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation. Phytother Res, 14, 149–152.
- Andresen TL, Jensen SS, Jørgensen K. (2005). Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res, 44, 68–97.
- Aung HH, Wang CZ, Ni M, Fishbein A, Mehendale SR, Xie JT, Shoyama CY, Yuan CS. (2007). Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol, 29, 175–180.
- Chen Y, Zhang H, Tian X, Zhao C, Cai L, Liu Y, Jia L, Yin HX, Chen C. (2008). Antioxidant potential of crocins and ethanol extracts of Gardenia jasminoides ELLIS and Crocus sativus L.: a relationship investigation between antioxidant activity and crocin contents. Food Chem, 109, 484–492.
- Chonn A, Cullis PR. (1995). Recent advances in liposomal drug-delivery systems. Curr Opin Biotechnol, 6, 698–708.
- Chonn A, Cullis PR. (1998). Recent advances in liposome technologies and their applications for systemic gene delivery. Adv Drug Deliv Rev, 30, 73–83.
- Debatin KM, Poncet D, Kroemer G. (2002). Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene, 21, 8786–8803.
- Fahr A, Holz M, Fricker G. (1995). Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics. Pharm Res, 12, 1189–1198.
- Farokhzad OC, Langer R. (2009). Impact of nanotechnology on drug delivery. ACS Nano, 3, 16–20.
- Fernndez J-A. (2006). Anticancer properties of saffron, Crocus sativus Linn. Adv Phytomed, 2, 313–330.
- Goyal P, Goyal K, Vijaya Kumar SG, Singh A, Katare OP, Mishra DN. (2005). Liposomal drug delivery systems—clinical applications. Acta Pharm, 55, 1–25.
- Green DR, Reed JC. (1998). Mitochondria and apoptosis. Science, 281, 1309–1312.
- He SY, Qian ZY, Tang FT, Wen N, Xu GL, Sheng L. (2005). Effect of crocin on experimental atherosclerosis in quails and its mechanisms. Life Sci, 77, 907–921.
- Hersey P, Zhang XD. (2001). How melanoma cells evade trail-induced apoptosis. Nat Rev Cancer, 1, 142–150.
- Hosseinzadeh H, Ziaee T, Sadeghi A. (2008). The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine, 15, 491–495.
- Kamps JAAM, Scherphof GL. (2003). Liposome in biological system. In: Torchilin VP, Weissig V, eds., Liposomes. Oxford, USA: Oxford University Press, pp. 267–301.
- Kono K, Iwamoto M, Nishikawa R, Yanagie H, Takagishi T. (2000). Design of fusogenic liposomes using a poly(ethylene glycol) derivative having amino groups. J Control Release, 68, 225–235.
- Kunisawa J, Nakagawa S, Mayumi T. (2001). Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development. Adv Drug Deliv Rev, 52, 177–186.
- Liakopoulou-Kyriakides M, Skubas AI. (1990). Characterization of the platelet aggregation inducer and inhibitor isolated from Crocus sativus. Biochem Int, 22, 103–110.
- Lv CF, Luo CL, Ji HY, Zhao P. (2008). [Influence of crocin on gene expression profile of human bladder cancer cell lines T24]. Zhongguo Zhong Yao Za Zhi, 33, 1612–1617.
- Malaekeh-Nikouei B, Davies N. (2009). Double loading of cyclosporine A in liposomes using cyclodextrin complexes. PDA J Pharm Sci Technol, 63, 139–148.
- Malaekeh-Nikouei B, Jaafari MR, Tabassi SA, Samiei A. (2008). The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes. Colloids Surf B Biointerfaces, 67, 238–244.
- Mousavi SH, Tavakkol-Afshari J, Brook A, Jafari-Anarkooli I. (2009). Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food Chem Toxicol, 47, 1909–1913.
- Pagano RE, Weinstein JN. (1978). Interactions of liposomes with mammalian cells. Annu Rev Biophys Bioeng, 7, 435–468.
- Pitsikas N, Boultadakis A, Georgiadou G, Tarantilis PA, Sakellaridis N. (2008). Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. Phytomedicine, 15, 1135–1139.
- Sheng L, Qian Z, Zheng S, Xi L. (2006). Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase. Eur J Pharmacol, 543, 116–122.
- Tavakkol-Afshari J, Brook A, Mousavi SH. (2008). Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol, 46, 3443–3447.
- Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov, 4, 145–160.
- Tripathi YB, Tripathi P, Arjmandi BH. (2005). Nutraceuticals and cancer management. Front Biosci, 10, 1607–1618.
- Zhang XD, Gillespie SK, Hersey P. (2004). Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways. Mol Cancer Ther, 3, 187–197.
- Zhao P, Luo CL, Wu XH, Hu HB, Lv CF, Ji HY. (2008). [Proliferation apoptotic influence of crocin on human bladder cancer T24 cell line]. Zhongguo Zhong Yao Za Zhi, 33, 1869–1873.
- Zheng YQ, Liu JX, Wang JN, Xu L. (2007). Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia. Brain Res, 1138, 86–94.